'Mercy' tops North American box office with $11.1M

Mercy topped the North American box office with $11.1 million in receipts, according to BoxOfficeMojo, followed by Avatar: Fire and Ash ($7.0M), Zootopia 2 ($5.7M), The Housemaid ($4.2M) and 28 Years Later: The Bone Temple ($3.6M). The report lists the full top-10 weekend totals (Marty Supreme $3.5M; Return from Silent Hill $3.3M; Hamnet $2.0M; The Lord of the Rings: The Fellowship of the Rings $2.0M; Primate $1.6M), providing a near-term revenue snapshot relevant to studio and exhibitor revenue flows and short-term trading considerations in media and leisure equities.

Analysis

Market structure: A $11.1M #1 weekend from a mid‑January title signals modest upside for theatrical exhibitors (IMAX, AMC, CNK) and franchise owners (Disney for Avatar/Zootopia sequels) rather than a full‑blown blockbuster cycle. Exhibitors gain a short‑term levered revenue lift—if Mercy holds >$8M for the next two weekends, domestic box office could run ~10–20% above Jan baselines, improving near‑term cashflow for indebted chains. Studios with repeatable IP retain pricing power on premium formats; smaller indies and pure‑play streamers face tighter negotiating leverage on pay windows.

Risk assessment: Tail risks include a sudden negative critic/word‑of‑mouth swing (>50% weekend drop) that forces impairment charges at studios or cash squeezes at marginal exhibitors, and regulatory shifts on theatrical/streaming windowing. Immediate effects play out over 1–4 weeks (box office momentum); medium (3–12 months) involves licensing/PVOD revenue shifts; long term (12+ months) is driven by franchise slate execution and international rollout. Hidden dependencies: international box office, merchandising, and streaming backend guarantees can flip economics fast; track PVOD timing within 30–90 days as a catalyst.

Trade implications: Tactical trades favor exhibitors that monetize premium formats—establish small, size‑controlled longs in IMAX (IMAX) and overweight Disney (DIS) relative to S&P leisure. Pair trade: long IMAX (1–2%) vs short AMC (AMC) or buy AMC 3‑month 30% OTM puts as a hedge against exhibitor dispersion. Options: buy a 3‑month IMAX call spread (buy ~25% OTM, sell ~50% OTM) sized to 1–2% portfolio risk; take profits at +15–25%, stop at −8–10%.

Contrarian angles: Consensus treats a No.1 weekend as bullish; empirical Januaries show high opening, steep decay—if 4‑week cumulative grosses <3x opening or week‑2 drop >50%, initial enthusiasm is overdone. Historical parallels (January sleepers) show high variance; the mispricing is concentration risk in small chains and high‑beta exhibitors while studios with diversified IP are underpriced for steady cash flow. Unintended consequence: accelerated PVOD/windowing reforms would tilt value from exhibitors back to studios/streamers—use box‑office decay metrics and studio release schedules as binary triggers to rebalance.

Key Decisions for Investors

• Establish a 1–2% long position in IMAX (IMAX) within 5 trading days and hedge with a 3‑month call spread: buy a ~25% OTM call and sell a ~50% OTM call, target +20% return within 1–3 months, stop‑loss at −8%.
• Overweight Disney (DIS) by +1% relative to benchmark on franchise pipeline exposure (Avatar/Zootopia), target 8–12% upside over 6–12 months; trim if stock underperforms market by >7% over a rolling 30‑day window.
• Initiate a 0.5–1% short or buy protection on AMC (AMC) via 3‑month puts ~30% OTM sized to offset long exhibitor exposure; unwind if AMC credit spreads tighten by >100bp or if box office 4‑week cumulative >4x opening.
• Use operational triggers for portfolio moves: if a film’s week‑2 drop >50% or 4‑week cumulative gross <3x opening, reduce exhibitor/leisure exposure by 50% within 5 trading days and rotate proceeds into studio/rights‑owner names (e.g., DIS) or non‑cyclical consumer staples.